Are We Facing a Tsunami of Vaccine Hesitancy or Outdated Pandemic Policy in Times of Omicron? Analyzing Changes of COVID-19 Vaccination Trends in Poland

Author:

Walkowiak Marcin Piotr1ORCID,Domaradzki Jan2ORCID,Walkowiak Dariusz3ORCID

Affiliation:

1. Department of Preventive Medicine, Poznan University of Medical Sciences, 60-781 Poznań, Poland

2. Department of Social Sciences and Humanities, Poznan University of Medical Sciences, 60-806 Poznań, Poland

3. Department of Organization and Management in Health Care, Poznan University of Medical Sciences, 60-356 Poznań, Poland

Abstract

In this study, we analyzed Polish COVID-19 vaccination data until January 2023 from the European Centre for Disease Prevention and Control to understand individual decision making during the milder Omicron wave. Our findings show a general decline in subsequent vaccine uptake. As the number of government-provided doses increased, completion rates among certain low-risk groups dropped to less than 1%. Elderly individuals, especially those aged 70–79, showed greater adherence but also exhibited decreased interest in subsequent boosters. Healthcare workers exhibited a dramatic shift in their attitude, disregarding the recommended schedule. The overwhelming majority opted out of receiving the second boosters, while the remaining individuals adjusted their timing based on infection trends or the availability of updated boosters. Two factors positively influenced vaccination decisions: societal influence and the availability of updated boosters. Lower-risk individuals were more likely to postpone vaccination until updated boosters were available. Our findings highlight that while Polish policy aligns with international guidelines, it fails to garner significant adherence from the Polish population. Previous studies have shown that vaccinating low-risk groups resulted in more sick days due to adverse events following immunization than the days gained by preventing infection. Consequently, we advocate for the official abandonment of this policy, as its practical abandonment has already taken place, and persisting in pretending otherwise only serves to erode public trust. Therefore, we propose a shift toward treating COVID-19-like influenza with vaccination for vulnerable individuals and those who have close contact with them before the season.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference70 articles.

1. (2023, May 23). Pierwszy Przypadek Koronawirusa w Polsce—Ministerstwo Zdrowia—Portal Gov.pl, Available online: https://www.gov.pl/web/zdrowie/pierwszy-przypadek-koronawirusa-w-polsce.

2. (2023, March 12). Rozporządzenie Ministra Zdrowia z Dnia 20 Marca 2020 r. w Sprawie Ogłoszenia Na Obszarze Rzeczypospolitej Polskiej Stanu Epidemii, Available online: https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20200000491.

3. (2023, March 23). European Medicines Agency EMA Recommends First COVID-19 Vaccine for Authorisation in the EU. Available online: https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu.

4. (2023, March 23). Narodowy Program Szczepień Przeciw COVID-19—Szczepienie Przeciwko COVID-19—Portal Gov.pl, Available online: https://www.gov.pl/web/szczepimysie/narodowy-program-szczepien-przeciw-covid-19.

5. (2023, May 12). „Ostatnia Prosta”! Nowa Kampania Narodowego Programu Szczepień, Available online: https://www.gov.pl/web/szczepimysie/ostatnia-prosta-nowa-kampania-narodowego-programu-szczepien.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3